Primary lymphoma cases analyzed for clusterin expression by immunohistochemistry
| Lymphoma subtype . | No. of cases . | Clusterin-positive . |
|---|---|---|
| T-cell lymphoma | ||
| Anaplastic large-cell lymphoma | 36 | 36 |
| Peripheral T-cell lymphoma | 38 | 0 |
| T/NK lymphoma | 7 | 0 |
| Cutaneous ALCL | 9 | 0 |
| Subtotal | 90 | 36 |
| B-cell lymphoma | ||
| Diffuse large B-cell lymphoma* | 31 | 1 |
| Follicle-center lymphoma | 11 | 0 |
| T-cell–rich large B-cell lymphoma* | 12 | 1 |
| Mantle-cell lymphoma | 5 | 0 |
| Marginal zone cell lymphoma | 9 | 0 |
| Chronic lymphocytic leukemia | 10 | 0 |
| Subtotal | 78 | 2 |
| Hodgkin lymphoma | ||
| Nodular sclerosis | 16 | 0 |
| Mixed cellularity | 3 | 0 |
| Lymphocyte depleted | 4 | 0 |
| Interfollicular Hodgkin lymphoma | 2 | 0 |
| Lymphocyte predominance | 5 | 0 |
| Subtotal | 30 | 0 |
| Total lymphoma cases | 198 | 38 |
| Lymphoma subtype . | No. of cases . | Clusterin-positive . |
|---|---|---|
| T-cell lymphoma | ||
| Anaplastic large-cell lymphoma | 36 | 36 |
| Peripheral T-cell lymphoma | 38 | 0 |
| T/NK lymphoma | 7 | 0 |
| Cutaneous ALCL | 9 | 0 |
| Subtotal | 90 | 36 |
| B-cell lymphoma | ||
| Diffuse large B-cell lymphoma* | 31 | 1 |
| Follicle-center lymphoma | 11 | 0 |
| T-cell–rich large B-cell lymphoma* | 12 | 1 |
| Mantle-cell lymphoma | 5 | 0 |
| Marginal zone cell lymphoma | 9 | 0 |
| Chronic lymphocytic leukemia | 10 | 0 |
| Subtotal | 78 | 2 |
| Hodgkin lymphoma | ||
| Nodular sclerosis | 16 | 0 |
| Mixed cellularity | 3 | 0 |
| Lymphocyte depleted | 4 | 0 |
| Interfollicular Hodgkin lymphoma | 2 | 0 |
| Lymphocyte predominance | 5 | 0 |
| Subtotal | 30 | 0 |
| Total lymphoma cases | 198 | 38 |
Eleven of 31 of the diffuse large B-cell lymphomas and 1 T-cell–rich B-cell lymphoma weakly or focally expressed CD30.